| Authors: |
Bui JK; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Allergy and Infection Diseases, University of Washington, Seattle, WA, USA., Starke CE; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA., Poole NH; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA., Rust BJ; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA., Jerome KR; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Kiem HP; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Allergy and Infection Diseases, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: hkiem@fredhutch.org., Peterson CW; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: cwpeters@fredhutch.org. |
